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Abstract
A constitutional guarantee of access to essential medicines has been identified as an important indicator 
of government commitment to the progressive realization of the right to the highest attainable standard of 
health. The objective of this study was to evaluate provisions on access to essential medicines in national 
constitutions, to identify comprehensive examples of constitutional text on medicines that can be used 
as a model for other countries, and to evaluate the evolution of constitutional medicines-related rights 
since 2008. Relevant articles were selected from an inventory of constitutional texts from WHO member 
states. References to states’ legal obligations under international human rights law were evaluated. 
Twenty-two constitutions worldwide now oblige governments to protect and/or to fulfill accessibility of, 
availability of, and/or quality of medicines. Since 2008, state responsibilities to fulfill access to essential 
medicines have expanded in five constitutions, been maintained in four constitutions, and have regressed 
in one constitution. Government commitments to essential medicines are an important foundation of 
health system equity and are included increasingly in state constitutions.
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Introduction
Essential medicines are an indispensable compo-
nent of health systems and are recognized as part 
of the right to health under international law.1 One 
indicator of a government’s commitment to ac-
cess to medicines and health system equity is the 
inclusion of medicines-related rights in national 
constitutions.2 Constitutional rights to health and 
medicines set priorities for national health policies 
and programs, while also creating the mechanisms 
necessary to enforce these rights before domestic 
courts.3 An initial scoping study conducted in 2008 
of 186 constitutions identified only three consti-
tutions worldwide that included provisions on 
medicines, and a fourth that provided for essential 
goods and services.4 Since then, many constitutions 
have been amended or redrafted, coinciding with 
recent economic, political, and social tensions 
linked to the 2008 financial crisis, the 2009 Euro-
pean debt crisis, and the 2011 Arab Spring.5 
Every constitutional review is an opportunity 
for the state to include health and medicines rights 
in the constitution, in line with human rights stan-
dards. The time is ripe to evaluate whether state 
constitutions recognize that essential medicines are 
part of the right to health. The starting point is a sur-
vey of the current provisions on essential medicines 
in national constitutions against the backdrop of 
states’ legal obligations under international human 
rights law and the right to health framework. We 
identify model text for policy makers and advocates 
seeking to enshrine these rights in their national 
constitutions. This study also develops an inventory 
of constitutional provisions on essential medicines 
in order to track their evolution since 2008. 
Essential medicines in international law
The right to the progressive realization of the high-
est attainable standard of health first emerged as 
a social right in the World Health Organization 
(WHO) Constitution.6 It was also included in Ar-
ticle 25.1 of the Universal Declaration of Human 
Rights (UDHR) and confirmed in numerous in-
ternational and regional treaties since then.7 The 
most important treaty in this respect, the binding 
International Covenant on Economic, Social and 
Cultural Rights (ICESCR), details the realization 
of the right to health through four concrete and 
targeted steps, including access to health facilities, 
goods, and services.8 The non-binding but highly 
respected General Comment No. 14, drafted by 
the Committee on Economic, Social and Cultural 
Rights (CESCR), further specifies in paragraph 
43(d) that access to essential medicines is part of 
the right to health. Paragraphs 34-37 of General 
Comment No. 14 clearly describe governments’ 
legal obligations to respect, protect, and fulfill the 
right to health. The duty to respect is a negative 
obligation to refrain from interfering with the 
enjoyment of health rights. The duties to protect 
and to fulfill impose positive obligations on states 
to take measures to safeguard (to protect) and to 
take measures to ensure that health rights can be 
enjoyed (to fulfill).9 This tripartite typology helps 
to identify the specific legal obligations of states 
to realize the right to health. Moreover, the right 
to health framework in General Comment No. 
14 (known as the AAAQ framework) enumerates 
the elements of the right to health as accessibility, 
availability, acceptability, and (assured) quality of 
goods and services, including essential medicines 
“as defined by the WHO Action Programme on 
Essential Drugs.”10 
WHO defines essential medicines as “those 
that satisfy the priority healthcare needs of the 
population. Essential medicines are chosen with 
due regard to disease prevalence, efficacy, safety 
and comparative cost-effectiveness.”11 According to 
WHO, essential medicines are used for disease pre-
vention, treatment, and control, and are applicable 
to most chronic and acute diseases.12 It is, therefore, 
of great concern that an estimated one-third of the 
population in developing countries is unable to 
access essential medicines on a regular basis.13 One 
way to address this unmet need is through national 
legislation that promotes a human rights approach 
to essential medicines.
The constitutional right to health and essential 
medicines
Most countries have ratified at least one of the 
international or regional treaties that include the 
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right to health, including 163 state parties to the 
International Covenant on Economic, Social and 
Cultural Rights (ICESCR).14 Access to essential 
medicines as part of the progressive realization of 
the right to health is well founded in international 
law and binding on many states. But do these laws 
mean anything in practice? Hogerzeil et al. identi-
fied 59 court cases from 12 low- and middle-income 
countries in which access to essential medicines 
was claimed under the right to health. Half of 
these cases related to life-saving treatment of HIV/
AIDS. The study showed that international trea-
ties, if enforced through constitutional provisions, 
could indeed promote the realization of individual 
rights at the national level. The examples identified 
by Hogerzeil et al., most of which are from Latin 
America, show that individual court cases can gen-
erate entitlements across a population group, that 
the right to health is not restricted by limitations in 
social security coverage, that government policies 
have successfully been challenged in court, and 
that states have special obligations towards the poor 
and disadvantaged. In the countries studied, other 
factors in successfully generating entitlements are a 
link between the right to health and the right to life 
(in case of life-threatening disease) and support by 
public interest NGOs.15
There is much variation in de jure constitu-
tional recognition of human rights and de facto 
application of these rights in practice.16 One example 
can be found in high-income countries, over half of 
which lack a constitutional right to health or medical 
care.17 At the same time, many high-income econo-
mies do have functioning health systems providing 
services and medicines on a regular basis. Despite 
this phenomenon, constitutional health rights are 
valuable tools to promote access to medicines. 
Hogerzeil et al. showed that one of the most import-
ant success factors for the practical implementation 
of access to essential medicines was the fact that the 
right to health principles of the international human 
right treaties had been incorporated into national 
constitutions.18 For this reason, the constitutional 
recognition of access to essential medicines is an 
indicator of government commitment to the right to 
health and health system equity.19 
Given that national constitutions have proven 
so important in realizing the right to health, the 
next question is: which countries have incorporat-
ed access to essential medicines in their national 
constitution? Our baseline study in 2008 identified 
provisions on essential medicines, goods, and ser-
vices in only four national constitutions worldwide: 
Mexico, Panama, the Philippines, and the Syrian 
Arab Republic.20 Since 2008, many governments 
have revised and amended existing constitutions or 
created new constitutions, sometimes in reaction to 
the changing political, social, and economic circum-
stances caused in part by the global financial crisis, 
the European debt crisis, and the Arab Spring.21 
The purpose of this study was to track the 
evolution of national constitutions and identify 
those that now include a specific reference to the 
legal obligations to respect, protect, and fulfill 
access to essential medicines as part of the right 
to health. We identified examples of constitutional 
texts that include the AAAQ elements of the right 
to health. These constitutional texts may serve as 
a model for other countries interested in updating 
or strengthening their own constitutions. Model 
constitutional provisions could assist domestic 
legislators in formulating an inclusive constitu-
tional health clause suited to national needs and 
resources. Patient and advocacy groups can also 
use the model texts in their efforts to advance uni-
versal access to essential medicines.
Methods 
A comprehensive inventory of constitutional texts 
from WHO member states was created. We con-
sidered essential medicines to be encompassed by 
the terms “medicines” and “vaccines,” as well as by 
“essential goods”, “services”, “supplies” and “aids”. 
We assembled an inventory of constitutional 
provisions from two points in time: those current-
ly in force and the version in force in 2007. The 
Chronology of the Comparative Constitutions 
Project was used to determine these two time points 
for each country.22 Constitutions were retrieved 
in English (preferred), Spanish, or French from six 
online databases: the Comparative Constitutions 
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Project, ConstitutionNet, Political Database of the 
Americas, International Constitutional Law, Consti-
tution Finder, and the African Human Rights Law 
Document Database.23 When necessary, a search 
term ([country], constitution, [year]) was also used 
in Google and the first 20 results were consulted. 
Once located, each constitution was searched 
for the keywords health, medical, medicines, phar-
maceutical, drug, vaccination, and vaccine (located 
using the stem vaccin if permitted by the search 
tool). The original language texts were consulted in 
cases of uncertainty. All search results were includ-
ed in the database. 
Analytical framework
This study analyzed national constitutions through 
international human rights standards elaborated 
in General Comment No. 14 on the right to health. 
The legal obligations and AAAQ framework de-
scribed in General Comment No. 14 use concise 
terminology to assert well-defined commitments to 
which governments can be held accountable. More-
over, clear references to human rights standards in 
national constitutions may facilitate their legal in-
terpretation. Melton et al. suggest that the scope of 
the constitutional text, such as whether it is focused 
by topic rather than using complex cross-referenc-
ing, and the use of once-only words for clarity and 
brevity, are of greater importance for clear inter-
pretation.24 Therefore, the legal obligations and the 
AAAQ framework were selected because they have 
brief, clear, and objective communication about 
governments’ commitments in realizing the right 
to health as related to essential medicines.
Legal obligations to essential medicines
Constitutional text was examined for each category 
of legal obligation: to respect, to protect, and to 
fulfill medicines-related rights. The first category, 
the obligation to respect the right to health as it 
relates to medicines, is described in paragraph 34 
of General Comment No. 14, as a duty of non-in-
terference.25 States must refrain from “denying or 
limiting equal access for all persons” and abstain 
from marketing unsafe medicines or otherwise 
interfering with the acceptability, availability, or 
accessibility of medicines. 26 An example of denying 
equal access to medicines for all persons would be 
limiting access to available contraceptives due to 
the nature of the medicine or the familial status of 
the patient. 
The second category, the obligation to protect 
the right to health as it relates to medicines, is ex-
plained in paragraph 35 of General Comment No. 
14 as the duties:
• to ensure that privatization of the health sector 
does not constitute a threat to the availability, 
accessibility, acceptability and quality of health 
facilities, goods and services; 
• [and] to control the marketing of medical equip-
ment and medicines by third parties.27 
This duty includes, for example, regulating the 
production and sale of medicines on the domes-
tic market. In essence, states must take measures 
to protect against interventions by third parties 
that could damage the provision of acceptable, 
accessible, and available medicines of good qual-
ity. Relevant third parties include pharmaceutical 
manufacturers, and they should be required by law 
to adhere to good manufacturing practices in order 
to produce medicines of assured quality. Pharma-
cists and medical prescribers should be adequately 
trained to help patients use medicine appropriately 
and by prescribing the right medicine, for the right 
patient, in the right dose, and for the right duration. 
The third category, the obligation to fulfill the 
right to health, was drawn from paragraph 37 of 
General Comment No. 14. In this provision, states 
are duty-bound to facilitate health rights by taking 
“positive measures that enable and assist individ-
uals and communities to enjoy the right”.28 States 
must also provide for health rights when an indi-
vidual or group is unable to provide medicines with 
the means at their own disposal.29 Finally states are 
obliged to promote the right to health by undertak-
ing “actions that create, maintain and restore the 
health of the population”.30 
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The obligation to fulfill requires states to take 
positive actions to enable rights holders to enjoy their 
right to health. For example, states are responsible to 
develop and maintain a health care system through 
which medicines are available, accessible (affordable, 
within physical reach, and free of discrimination), 
acceptable, and of assured quality. States also have 
the duty to provide medicines to the impoverished 
and to individuals who cannot otherwise access 
them, such as prisoners or ethnic minorities. 
We applied this typology to determine the 
prevalence of each category of obligation by WHO 
region and by national income.31 In addition, we 
noted the terminology used to describe duties to 
fulfill access to essential medicines. 
AAAQ framework applied to essential medicines
In order to identify model text, we selected con-
stitutional provisions in each category of legal 
obligations that satisfied the greatest number of 
right to health elements described in General 
Comment No. 14 as accessibility, availability, ac-
ceptability, and (assured) quality. We view these 
elements as being complimentary to the legal ob-
ligations in the sense that the AAAQ framework 
elaborates on the multiple elements needed to fully 
enjoy the respect, protection, and fulfillment of 
medicines-related rights. 
The AAAQ elements, defined in paragraph 
12 of General Comment No. 14, require that health 
goods and services be available in sufficient quanti-
ty, accessible to all without discrimination, within 
safe physical reach (called physical accessibility), 
and at an affordable price (called economic ac-
cessibility), as well as ensuring the accessibility of 
information about health issues (called informa-
tion accessibility). Health goods and services must 
also be acceptable from a cultural and generational 
standpoint, and they must respect medical ethics. 
Medicines must be available in a form that is usable 
by unconscious patients and people with difficulty 
swallowing, as well as in very small dosages for 
neonates. Their quality must be assured and health 
goods and services must be scientifically and med-
ically appropriate. Provisions that addressed the 
greatest number of AAAQ elements are presented 
as model text.
Finally, to understand how duties to fulfill 
medicines rights have changed since the 2008 
global financial crisis, we compared texts in our da-
tabase from constitutions in force in 2007 to those 
currently in force. The similarities and differences 
were noted. 
Results
Overview of constitutional medicines rights 
worldwide
Current constitutions of 185 WHO member 
states were retrieved. Of the 185 constitutions, no 
constitutions include the obligation to respect med-
icines-related rights, while 14 constitutions (7.6%) 
include provisions to protect and 13 (7%) to fulfill 
medicines-related rights. (See Table 1 below.) The 
constitutional duties to protect and fulfill access to 
essential medicines were not mutually exclusive and 
a total of 22 constitutions enshrined at least one of 
these legal obligations. The constitutional duty to 
fulfill utilized the terminology access to medicines 
(n=3), vaccination (n=2), medicines (n=4), essential 
goods and services including medical aids (n=3), and 
mechanisms to control the costs of medicines (n=1). 
Worldwide, protecting and fulfilling medi-
cines-related rights were most often enshrined in 
constitutions in the Pan-American (PAHO) region, 
followed by the European (EURO) and African 
(AFRO) regions. Two constitutions in the Eastern 
Mediterranean region (EMRO) enshrined duties 
to fulfill (9%) while duties to protect were absent 
in this region. Medicines-related rights are notably 
absent from the South-East Asia (SEARO) region 
and scarce in the Western Pacific region (WPRO)
(4% of WPRO constitutions), with the exception of 
the Philippines.
The majority of provisions on medicines were 
identified in middle-income economies enshrining 
the obligation to protect (n=12) and to fulfill (n=10) . 
Only two high-income economies, Portugal and the 
Czech Republic, included duties to protect and/or to 
fulfill in their constitutions. Only one low-income 
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economy, Mozambique, imposed the state responsi-
bility to protect medicines-related rights. A second 
low-income economy, Niger, cited the duty to fulfill 
to essential needs and services in its constitution. 
Model constitutional text to protect and fulfill 
the right to essential medicines
Model constitutional text was sought from our 
database and reproduced below in order to make it 
accessible for future constitutional framers. 
We did not identify any constitutional text 
requiring states to respect medicines rights as part 
of the right to health.
We identified two types of provisions con-
cerning the duty to protect access to essential 
medicines. The first is a state obligation to monitor 
pharmaceutical supplies to protect citizens against 
the provision of poor quality medicines by third 
parties. El Salvador’s Constitution provides:
The State shall be equipped with the necessary and 
indispensable resources for permanent control of the 
quality of chemical, pharmaceutical and veterinary 
products through surveillance organisms.32 
This provision creates a duty to protect because the 
state is obliged to monitor the quality of medicinal 
products marketed by third parties. Interestingly, 
this text also requires the state to provide “in-
dispensable resources” for it to carry out these 
Country WHO Region Income level Year of 
adoption
Respect Protect Fulfill
Angola AFRO UMI 2010 ✓
Bolivia PAHO LMI 2009 ✓ ✓
Brazil PAHO UMI 2014 ✓
Bulgaria EURO UMI 2007 ✓
Cape Verde AFRO LMI 2010 ✓
Cuba PAHO UMI 2002 ✓
Czech Republic EURO HI 2013 ✓
Dominican Republic PAHO UMI 2010 ✓
Ecuador PAHO UMI 2011 ✓ ✓
Egypt EMRO LMI 2014 ✓
El Salvador PAHO LMI 2009 ✓
Guatemala PAHO LMI 1993 ✓
Honduras PAHO LMI 2013 ✓
Mexico PAHO UMI 2014 ✓
Mozambique AFRO LI 2007 ✓
Niger AFRO LI 2010 ✓
Panama PAHO UMI 2004 ✓
Paraguay PAHO LMI 2011 ✓ ✓
Philippines WPRO LMI 1987 ✓ ✓
Portugal EURO HI 2005 ✓ ✓
Suriname PAHO UMI 1992 ✓
Syrian Arab Republic EMRO LMI 2012 ✓
Abbreviations used in this table: AFRO: WHO Africa Region; EMRO: WHO Eastern Mediterranean Region; EURO: WHO European Region; 
PAHO: WHO Pan-American Region; SEARO: WHO South East Asia Region; WPRO: WHO Western Pacific Region; LI: Low-income economy; 
LMI: Lower-middle-income economy; UMI: Upper-middle-income economy; HI: High-income economy
Table 1. Global view of medicines-related rights in national constitutions. 
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activities without interruption. However, the text 
does have some deficiencies. While it refers to qual-
ity control, it does not address regulation of the 
safety, efficacy, and quality of medicines entering 
the market, which are equally important. In Portu-
gal, the Constitution provides that the state shall be 
under a primary duty to “regulate and control the 
production, distribution, marketing, sale and use of 
chemical, biological and pharmaceutical products 
and other means of treatment and diagnosis.”33 This 
text, addressing the duty to protect, goes beyond 
the regulation of medicines produced by third par-
ties. Here, the state is obliged to control medicines 
throughout their lifecycle by regulating the acts 
of third parties in their “production, distribution, 
marketing, sale and use.”34
The second type of protection of medicines 
rights is a novel addition to constitutional law: the 
declaration that international trade agreements shall 
not interfere with access to medicines. This new 
phrasing was introduced in two Latin American con-
stitutions. In Bolivia, the Constitution provides that 
“the right to access medicine shall not be restricted 
by intellectual property rights and commercial 
rights, and it contemplates quality standards and 
first generation medicine.” 35 Moreover, the Bolivian 
Constitution specifies that negotiation, signing and 
ratification of international relations shall preserve 
“the right of the population to have access to all 
medications, primarily generic medications”.36 
Cuba
Egypt
Cape Verde
Portugal
Bolivia
Dominican Republic
Ecuador
Mexico
Panama
Paraguay
Syria
Czech Republic
Niger
Philippines
201520081999
Vaccination
Public financing of medicines
Access to medicines
Medicines
Essential goods & services
Right to health
No health right
Figure 1. Evolution of the duty to fulfill medicines-related rights in constitutions since 2008.
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In Ecuador, the Constitution provides:
The application of international trade instruments 
shall not undermine, either directly or indirectly, the 
right to health, access to medicine, inputs, services 
or scientific and technological breakthroughs.37
These provisions protect the right to access medicines 
from being limited by the actions of third parties, 
including the application of international trade in-
struments and/or intellectual property rights. 
The most comprehensive obligations to ful-
fill medicines entitlements embodied the AAAQ 
framework and were identified in the constitutions 
of Ecuador and Panama. In Ecuador, the Constitu-
tion provides that the state shall be responsible for:
“Guaranteeing the availability and access to quality, 
safe and effective medicines, regulating their mar-
keting, and promoting the national production and 
use of generic drugs that meet the epidemiological 
needs of the population. With respect to access to 
medicine, public health interests shall prevail over 
economic and commercial interests.38 
This text cites the state’s duty to ensure the availabil-
ity, quality, and accessibility of medicines, although 
the type of accessibility is unclear. It is positive that 
the text also supports the rational use of medicines 
by regulating their marketing and promoting generic 
use; these aspects are often missing from government 
commitments despite states’ crucial role in creating 
conditions for appropriate use of medicines.
Panama’s Constitution identifies the 
State as having a primary obligation to devel-
op certain activities and facilities with the aim 
of prevention, cure and rehabilitation, including: 
“[The] Establishment, in accordance with the re-
quirements of each region, of centers which provide 
comprehensive health care services, and supply 
medicines to all the people. These services and med-
icines shall be given free to those who lack economic 
means to purchase them.” 39
In this text, the government is obliged to provide 
medicines universally and free of charge to those 
who cannot afford them; this is otherwise known 
as economic accessibility. 
Evolution of the duty to fulfill access to essential 
medicines as part of the right to health
We retrieved 108 constitutions that have undergone 
review since 2008. Of these countries, the obligation 
to fulfill medicines-related rights was introduced 
in five constitutions, maintained in four constitu-
tions, and has regressed in one constitution. Figure 
1 compares the terminology used before and after 
the constitutional revision (marked by vertical 
black lines) in these 10 countries.
Of the five countries that have expanded 
health rights, Ecuador, Bolivia, and the Dominican 
Republic introduced medicines-related rights in 
their newly drafted constitutions for the first time 
in 2008, 2009, and 2010 respectively (see Figure 
1 and Table 2). These three upper-middle-income 
economies introduced the term “access to medi-
cines” into their constitutions. A fourth country, 
Niger, introduced the right to “essential needs 
and supplies” into its constitution in 2010. Finally, 
Egypt introduced the right of children to “free 
compulsory vaccinations” in its new constitution 
in 2014. 
Of the four constitutions in which health 
rights have remained static through recent consti-
tutional revisions, three provide for “medicines” 
(Mexico, the Syrian Arab Republic, and Paraguay) 
and one provides for “medical aids” (Czech Repub-
lic) (see Table 2).
Provisions on medicines in Cape Verde’s Con-
stitution regressed following amendments made 
in 2010 (See Figure 1 above). The state’s duty to 
promote the “socialization of medicines costs” was 
removed from the right to health.40
Discussion
Twenty-two constitutions now oblige governments 
to protect or to fulfill accessibility, acceptability, 
availability, and/or quality of medicines as part of 
the right to health. Thirteen of these constitutions 
create a state duty to fulfill medicines-related rights: 
four adopted before 2008 in which these rights were 
included; four amended after 2008 in which these 
rights were maintained; and five amended after 
2008 in which these rights were expanded. Nota-
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bly, terminology used to describe these rights has 
evolved over time to be more inclusive of human 
rights standards. Recently adopted constitutions 
enshrine the obligation to fulfill access to medicines 
and to protect medicines access from barriers in 
international trade agreements and/or intellectual 
property rights. Model text to protect and to fulfill 
essential medicines-related rights was identified 
and includes the elements of access, availability, 
and quality.
Country WHO Region
World Bank 
lending 
group
Current Constitution
Change in duty to 
fulfill since 2008Terminology describing 
duty to fulfill
Year of 
adoption
New or amended 
constitution
Egypt EMRO LMI Vaccination 2014 New Added
Mexico PAHO UMI Medicines 2014 Amended Maintained
Czech Republic EURO HI Medical aids 2013 Amended Maintained
Syrian Arab Republic EMRO LMI Medicines 2012 New Unclear^
Ecuador PAHO UMI Access to medicines 2011 Amended* Added
Paraguay PAHO LMI Medicines 2011 Amended Maintained
Dominican Republic PAHO UMI Access to medicines 2010 New Added
Niger AFRO LI Essential needs and services 2010 New Added
Bolivia PAHO LMI Access to medicines 2009 New Added
Portugal EURO HI Public financing of medicines costs 2005
Panama PAHO UMI Medicines 2004
Cuba PAHO UMI Vaccination 2002
Philippines WPRO LMI Essential goods and services 1987
Abbreviations used in this table: AFRO : WHO Africa Region; EMRO : WHO Eastern Mediterranean Region; EURO : WHO European Region; 
PAHO : WHO Pan-American Region; SEARO : WHO South East Asia Region; WPRO : WHO Western Pacific Region; LI : Low-income economy; 
LMI : Lower-middle-income economy; UMI: Upper-middle-income economy; HI : High-income economy
*Amended – A new constitution was adopted in Ecuador in 2008 that introduced the medicines-related rights described here for the first time. 
This constitution was last amended in 2011. 
^ Please see the discussion section of this article for our comments on the limitations of determining whether this provision has changed since 2008.
Table 2. Government duties to fulfill medicines-related rights in national constitutions. 
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The most prevalent and comprehensive 
constitutional rights to medicines were identified 
in middle-income economies, many from the 
Pan-American region. Flood et al. describe several 
justifications of the so-called ‘resurgence’ of the 
right to health in international and domestic law 
that may explain why medicines-related rights are 
appearing more frequently in constitutions. 41 Sev-
eral applicable justifications are that health rights 
are a reaction to neoliberal economic policies or 
healthcare reform that may reduce government 
services and privatize health care, particularly 
in Latin America, possibly resulting in delayed 
or denied care.42 Another hypothesis behind the 
resurgence of the right to health is the rise of free 
trade agreements in which intellectual property 
(IP) protection and enforcement is at odds with the 
provision of affordable generic medicines.43 A final 
explanation may be governments’ own ambitions 
to “accelerate an equity and equality agenda” in na-
tions with sizable income disparities resulting from 
dictatorship and apartheid.44 
This study identified a lack of constitutional 
medicines-related rights in WHO South East Asia 
Region. In contrast, Heymann et al. demonstrated 
that the constitutional protection of free health 
care was most common in the South Asia region.45 
Despite a legal culture of enshrining health com-
mitments in South Asian constitutions, our findings 
suggest that essential medicines have not yet been 
explicitly embraced as part of these commitments. 
No obligations to respect essential medicines 
were retrieved as part of the right to health, signal-
ing that governments are perceived as having only 
positive duties towards medicines. As an example, 
positive duties include facilitating access through 
health services or providing health services and 
goods to the impoverished. Only one example of 
the duty to respect medicines-related rights was 
created in the context of a peace agreement be-
tween the government and the communist party, 
and subsequently included within the Constitution 
of Nepal (2010). Nepal’s Constitution states, “Both 
parties shall not hinder drug supplies and aid and 
health related campaigns.”46 Other governments 
confronted with conflict may wish to adopt simi-
lar language in order to establish the clear duty to 
respect the availability of medicines, and may con-
sider further expanding the provision to include 
the duty to affordability, acceptability, and quality 
of medicines.
New strategies for articulating state 
commitments to medicines 
This study has identified how constitutions frame 
state commitments to medicines and, in this pro-
cess, has revealed new strategies to articulate these 
duties. The first strategy reveals a shift of medi-
cines-related provisions nested within the right to 
health, to now also being a part of consumer rights. 
We observed this strategy in the Bolivian Constitu-
tion (2009), which states that users and consumers 
enjoy the right to the supply of pharmaceuticals “in 
harmless and quality condition, in sufficient and 
adequate quantity, and with efficient service and 
timely supply”.47 Users and consumers also have the 
right “to reliable information about the characteris-
tics and contents of the products they consume and 
of the services they use.”48 Here, the Constitution 
references access to medicines of good quality; suit-
able availability of medicines, that is, “in sufficient 
and adequate quantity”; and access to information 
about medicinal products.49 This strategy aims to 
include access to information about medicines, as 
well as access to quality of medicines, as funda-
mental basic consumer rights.
The second strategy shows the introduction 
of constitutional provisions to protect access to 
medicines from potentially harmful IP standards 
in international trade agreements. The Bolivian 
and Ecuadorian governments have explicitly stated 
in their constitutions that IP rights or trade instru-
ments shall not undermine access to medicines.50 
This strategy likely evolved after a decade of academic 
debate about and civil society advocacy for a human 
rights approach to IP standards in international 
trade agreements, particularly in Latin America.51 
Moreover, the constitutions of Ecuador and Bolivia 
include provisions on “generic medicines”, a phrase 
that could serve to shield legitimate generics from 
confusion with substandard and falsified medi-
cines.52 Confusing legitimate generic medicines with 
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substandard and falsified medicines is a misunder-
standing with drastic consequences for affordable 
and accessible medicines in developing countries.53 
The term “generic medicines” could also be used 
to proactively guide national policy and to create a 
supportive environment for local generic industry, 
generic procurement, and generic prescribing.
Promoting access to medicines through 
constitutional commitments
All in all, governments committed to improving 
access to medicines can include these rights in their 
national constitutions, which are counted among 
the most vital expressions of state responsibilities 
and individual rights. Admittedly much variation is 
noted worldwide between de jure constitutional law 
(the rights and duties in the constitution) and de 
facto law (the rights and duties actually enforced).54 
However, enshrining medicines-related rights does 
facilitate a number of mechanisms to promote ac-
cess to medicines. Constitutional medicines-related 
rights can guide the implementation and revision 
of national laws and policies. Two examples of this 
practice are the national health policies in South 
Africa and Bangladesh that give effect to the con-
stitutional commitments to healthcare provision.55 
Moreover, in a climate of austerity or political or 
social instability, a constitutional framework in 
which access to medicines is a clear priority can aid 
government decision making in order to prevent a 
regression of health rights. 
Another advantage of clear constitutional 
commitments to access to medicines is that they can 
be monitored and targets can be set. Governments, 
researchers, and civil society organizations already 
conduct proactive monitoring. Since 2003, country 
surveys are undertaken using a method developed 
by Health Action International and WHO, and the 
results are publicly available online.56 In addition, 
some governments support household surveys 
to monitor financial and geographic accessibili-
ty, as well as institutional surveys to monitor the 
availability of medicines at health care facilities.57 
Through these monitoring exercises, stakehold-
ers can evaluate progress towards the progressive 
realization of health and medicines-related rights 
provided by their constitution. Some civil society 
organizations, such as the Treatment Action Cam-
paign in South Africa, not only monitor access to 
medicines, but in cases of insufficient provision, they 
have also claimed their rights through the courts.58
Monitoring access from the perspective of public 
health and human rights
Public health and law propose distinct analyti-
cal frameworks through which pharmaceutical 
legislation can be analyzed. From a public health 
perspective, WHO’s Framework for Equitable 
Access to Essential Medicines proposes steps nec-
essary to achieve access within a health system. 
First, essential medicines should be selected and 
used rationally, then they should be available at 
affordable prices, and sustainable financing mech-
anisms—such as public funding—should be in 
place. Second, reliable health and supply systems 
should regulate, procure, and distribute essential 
medicines.59 Legal frameworks, on the other hand, 
take a human rights approach derived from Gener-
al Comment No. 14. This approach first considers a 
government’s negative duty to refrain from inter-
fering with health rights, followed by its positive 
duty to protect individuals from deleterious inter-
ference by others (such as the sale of low-quality 
medicines). Last, states have a positive obligation to 
facilitate individuals’ enjoyment of medicines-re-
lated rights and to provide medicines to individuals 
unable to do so for themselves. This includes an im-
mediate duty to satisfy minimum core obligations 
towards health, including the provision of essential 
medicines.60 
When taken together, a combined public 
health and human rights framework holds the 
greatest potential to achieve universal access to 
medicines. The Global Health Law Groningen 
Research Centre applies this combined framework 
in its Essential Laws for Medicines Access project 
to identify sound domestic laws and policies that 
promote access.61 
WHO supports countries to establish and im-
plement their own comprehensive national policies 
on medicines. WHO’s Mid-Term Strategic Plan 
2008-2013 offered several indicators to monitor and 
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measure progress in countries. Indicators included 
measures of the following: a constitutional provision 
and/or domestic legislation recognizing the right 
to essential medicines (structural indicator); regu-
latory capacity (process indicator); vaccine quality, 
prescribing appropriateness; and essential medicines 
availability and price (outcome indicator).62 
In 2008, Backman et al. expanded on these 
indicators to include measures on: a national policy 
on medicines and an essential medicines list (struc-
tural indicators); the public per capita spending on 
pharmaceuticals (process indicator); and the rate of 
immunization coverage (outcome indicator).63 The 
initial figures reported by Backman et al. for 194 
countries serve as a baseline measurement of glob-
al access to medicines, rather than an analysis of 
the relationship between domestic laws, programs 
and access outcomes. At the same time, other sin-
gle-country case studies have explored domestic 
pharmaceutical policy frameworks and their impli-
cations for access.64 
Despite much interest in these indicators 
and case studies, the authors are not aware of any 
systematic or comparative research that studies 
the relationship between constitutional rights, 
domestic legislation and programs, and access to 
medicines on the ground. There is a demonstrated 
need for more research on domestic laws and poli-
cies that support universal access.
Potential barriers to access to medicines 
Medicines are an essential part of every health 
system and, as such, access to medicines is highly 
interconnected to other factors that transcend do-
mestic legislation and programs. Bigdeli et al. argue 
that the complexity of health systems can create 
potential barriers to access to medicines at multiple 
levels.65 First, barriers at the individual/community 
level include the cost and perceived quality of med-
icines, health-seeking behavior, and socio-cultural 
elements, such as poverty.66 Second, at the level of 
health service delivery, low availability, high price, 
and substandard quality of medicines are again 
barriers.67 Other barriers include the overall quality 
of health services--including irrational prescribing 
and dispensing—and competition between public 
and private health care services.68 Third, barriers 
can arise at the level of the health sector primarily 
concerning pharmaceutical sector governance (that 
is, at all stages in the lifecycle of medicines, from 
their registration on the market to their promo-
tion to prescribers and consumers), medicines 
price control particularly in procurement, and 
overall health sector governance and pluralism.69 
Fourth, overarching public policies can create 
barriers such as low public accountability and 
transparency, low priority of social sectors such 
as health, and corruption or the high burden of 
government bureaucracy.70
Conflict between trade and economic and 
public health goals for the pharmaceutical sector, 
especially in countries with strong local medicines 
production, can also stifle access to medicines.71 
Finally, international and regional policies can also 
challenge access to medicines in situations where 
patents and IP rights are used unethically, inter-
national donors’ agendas are poorly aligned with 
disease burden, and/or research and development 
priorities are set by profitability rather than medical 
need.72 Access to medicines is best supported through 
a wide health systems approach where medicines are 
embedded and addressed at each level.73 
The pharmaceutical industry has a significant 
role to play at all levels of the health system. Ethi-
cal medicines promotion can help limit irrational 
medicines-seeking behavior on the part of patients 
and curb inappropriate prescribing on the part of 
physicians. Transparent pricing policies, including 
differential pricing and market segmentation, can 
empower poorer members of the populations to ob-
tain essential medicines at affordable prices. Drug 
companies can further embrace voluntary licenses 
to make a range of lifesaving medicines available 
in many markets.74 Concerning international trade 
agreements, companies can bring their market 
interests in line with global public health protec-
tions, such as the flexibilities in the Agreement on 
Trade-Related Aspects of Intellectual Property 
Rights (TRIPS), and refrain from seeking extensive 
IP protection for their products. Finally, companies 
can foster in-house or support external research and 
development into medicines for neglected diseases.75 
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It is important to note that, unlike our present 
research, our survey in 2008 identified only four 
constitutions that cited access to or the provision of 
essential goods and medicines. In contrast to this 
limited scope, our present study addresses duties 
to respect, protect, and fulfill; that is, not only to 
provide, but also to facilitate and promote essential 
medicines-related rights. Moreover, high-quality, 
reliable databases enabled us to locate constitutions 
in our present survey that we previously could not 
retrieve. These factors contribute to the higher 
numbers of relevant constitutional texts reported 
in this article than in our previous research. 
Strengths and limitations of this research
The present study has several limitations. First, we 
were unable to retrieve the text of 10 constitutions. 
Any medicines-related rights in these laws are 
therefore not described in our study. Second, of 
the constitutions amended after 2008 (n=109), we 
were unable to retrieve 34 constitutions in force 
at the first point in time (2007). However, we did 
retrieve the constitutions currently in force from all 
34 countries, and no provisions on medicines were 
identified in these documents. This result, together 
with the findings from our initial study in 2008, 
suggests that no provisions on medicines have gone 
unidentified in the 34 irretrievable constitutions 
from 2007, but we cannot be certain. 
Similarly, we were unable to retrieve the 
Syrian Constitution in force at the first point in 
time (this was an amendment of the constitution 
adopted in 1973). Both of the constitutions adopted 
in 1973 and 2012 (currently in force), however, in-
clude medicines as part of the right to health, which 
strongly suggests that the provision of medicines is 
not a recent development; this is shown in Figure 1. 
Third, constitutional law scholars Elkins, 
Ginsburg, and Melton articulated the difficulties of 
analyzing and comparing constitutional language 
based on their experience with the Comparative 
Constitutions Project. Two main difficulties of 
constitutional comparison are a lack of conceptual 
clarity of the topic studied and atypical or “fuzzy” 
constitutional text.76 Our present study addressed 
the former challenge by using the well-developed 
essential medicines concept from authoritative 
sources such as WHO and applying the tripartite 
typology from global human rights instruments. 
We minimized the latter challenge by consulting a 
second source or the original language text when 
the constitutional language was obscure. 
Conclusion
This study demonstrates the value of a human 
rights approach to governments seeking to make 
clear commitments to essential medicines as part 
of the constitutional right to health. Our study il-
lustrates that these commitments have multiplied 
since 2008 and are now found in 22 constitutions. 
In 13 of these constitutions, states are duty-bound 
to fulfill medicines-related rights, some of which 
now use access to medicines terminology. In gener-
al, medicines-related rights have been maintained 
or enhanced in constitutions revised since 2008. As 
an empirical measurement of the development of 
medicines-related rights, these results can be used 
to monitor the evolution of constitutional aspira-
tions. The examples of constitutional text identified 
in this study can perhaps serve as a model to states 
motivated to achieve the universal right to health. 
Future research can address the domestic 
interpretation and application of constitutional 
medicines provisions in order to further elucidate 
the role of constitutional commitments in pro-
moting universal access to medicines. In any case, 
constitutional commitments to medicines as a part 
of the right to health are an important foundation 
of health system equity and are, encouragingly, 
being established in ever more countries. 
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